GlobeNewswire
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
📈
AI Sentiment
Highly Positive
10/10
Tempest Therapeutics Inc. News
Latest updates and market news for TPST
1 news
Feb 21 - Feb 27, 2026
Page 1
Share this news page